BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32692719)

  • 1. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells.
    Zheng X; Wei J; Li W; Li X; Wang W; Guo J; Fu Z
    Aging (Albany NY); 2020 Jul; 12(16):16390-16409. PubMed ID: 32692719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling.
    Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
    Cancer Lett; 2014 Feb; 343(2):190-9. PubMed ID: 24125860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
    Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
    Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
    Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
    Mol Cell Biochem; 2014 Feb; 387(1-2):261-70. PubMed ID: 24234423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
    Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
    Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
    Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
    Wang W; Wei J; Zhang H; Zheng X; Zhou H; Luo Y; Yang J; Deng Q; Huang S; Fu Z
    Cell Death Dis; 2021 Jun; 12(6):605. PubMed ID: 34117220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
    Peng L; Wang R; Shang J; Xiong Y; Fu Z
    Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
    Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
    Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
    Yang Z; Chen Y; Wei X; Wu D; Min Z; Quan Y
    Int J Oncol; 2020 Jun; 56(6):1442-1454. PubMed ID: 32236587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of long noncoding RNA urothelial carcinoma associated 1 inhibits colorectal cancer cell proliferation and promotes apoptosis via modulating autophagy.
    Song F; Li L; Liang D; Zhuo Y; Wang X; Dai H
    J Cell Physiol; 2019 May; 234(5):7420-7434. PubMed ID: 30362538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.
    Liu Q; Guo L; Qi H; Lou M; Wang R; Hai B; Xu K; Zhu L; Ding Y; Li C; Xie L; Shen J; Xiang X; Shao J
    Cell Death Dis; 2021 Jul; 12(7):683. PubMed ID: 34234118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
    Chuerduangphui J; Ekalaksananan T; Heawchaiyaphum C; Vatanasapt P; Pientong C
    PLoS One; 2020; 15(12):e0242465. PubMed ID: 33332365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
    Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
    Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing Oxiconazole against Colorectal Cancer via PRDX2-mediated Autophagy Arrest.
    Shi J; Zhou L; Huang HS; Peng L; Xie N; Nice E; Fu L; Jiang C; Huang C
    Int J Biol Sci; 2022; 18(9):3747-3761. PubMed ID: 35813474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Athamneh K; Alneyadi A; Alsamri H; Alrashedi A; Palakott A; El-Tarabily KA; Eid AH; Al Dhaheri Y; Iratni R
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32155920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of peroxiredoxin-2 in colon cancer stem cells.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Fu Z
    Aging (Albany NY); 2021 Mar; 13(8):11170-11187. PubMed ID: 33819194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.